Oral calorie supplements for cystic fibrosis

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Smyth, Rosalind L ^a   Walters, Sarah ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

*Dietary supplements; *Energy intake; Adult; Child; Child nutrition disorders *diet therapy; etiology ; Cystic fibrosis *complications ; Humans; Randomized controlled trials as topic

Indexed keywords

ANTHROPOMETRY; BODY COMPOSITION; BODY MASS; CALORIC INTAKE; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE COURSE; DISEASE SEVERITY; FEEDING BEHAVIOR; GASTROINTESTINAL SYMPTOM; HEALTH SERVICE; HUMAN; LUNG FUNCTION; NUTRITIONAL ASSESSMENT; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; QUALITY OF LIFE; REVIEW; WEIGHT CHANGE;

EID: 77950255717     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Hanning 1993 {published data only} Hanning RM, Blimkie CJR, Bar-Or O, Lands LC, Moss LA, Wilson WM. Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?. American Journal of Clinical Nutrition 1993;57(4):580-7.
2. Kalnins 2005 {published and unpublished data} * Kalnins D, Corey M, Ellis L, Pencharz PB, Tullis E, Durie PR. Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics 2005;147(3):399-401.
3. Kalnins D, Durie PR. Oral supplements vs normal food intake in children and adults [abstract]. Israel Journal of Medical Sciences 1996;32:S120-S121.
4. Kalnins D, Durie PR, Corey M, Ellis L, Pencharz P, Tullis E. Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF? [abstract]. Pediatric Pulmonology 1996;Suppl 11:314-5.
5. Poustie 2006 {published and unpublished data} Poustie VJ, Russell JE, Watling RM, Ashby D, Smyth RL. Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis [abstract]. Journal of Cystic Fibrosis 2004;3(Suppl 1):S79.
6. Poustie VJ, Russell JE, Watling RM, Ashby D, Smyth RL. Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis [abstract]. Journal of Cystic Fibrosis 2004;3(Suppl 1):S76.
7. * Poustie VJ, Russell JE, Watling RM, Ashby D, Smyth RL, on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ 2006;332(7542):632-6.
8. Poustie VJ, Russell JE, Watling RM, Ashby D, Smyth RS. The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis [abstract]. Pediatric Pulmonology 2004;38(Suppl 27):333.
9. Abdulhamid 2008 {published data only} * Abdulhamid I, Beck FW, Millard S, Chen X, Prasad A. Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis. Pediatric Pulmonology 2008;43(3):281-7.
10. Abdulhamid I, Millard S, Beck F, Chen X, vanWagnen C, Prasad A. Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis [abstract]. Pediatric Pulmonology 2005;40(Suppl 28):348.
11. Best 2004 {published data only} Best K, McCoy K, Gemma S, Disilvestro RA. Copper enzyme activities in cystic fibrosis before and after supplementation plus or minus zinc. Metabolism 2004;53(1):37-41.
12. Bruzzese 2007 {published data only} Bruzzese E, Raia V, Spagnuolo MI, Volpicelli M, De Marco G, Maiuri L, et al.Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clinical Nutrition 2007;26(3):322-8.
13. Caramia 2003 {published data only} Caramia G, Cocchi M, Gagliardini R, Malavolta M, Mozzon M, Frega NG. Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture. Pediatria Medica E Chirurgica 2003;25(1):42-9.
14. Ellis 1998 {published data only} Ellis L, Kalnins D, Corey M, Brennan J, Pencharz P, Durie P. Do infants with cystic fibrosis need a protein hydrolysate formula? A prospective, randomized, comparative study. Journal of Pediatrics 1998;132:270-6.
15. Grey 2003 {published data only} * Grey V, Mohammed SR, Smountas A, Bahlool R, Lands L. Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. Journal of Cystic Fibrosis 2003;2(4):195-8.
16. Lands LC, Grey VL. Oral supplementation with a bovine whey protein isolate can increase intracellular and sputum glutathione levels in patients with cystic fibrosis [abstract]. Pediatric Pulmonology 2000;Suppl 20:253.
17. Haworth 2004 {published data only} Haworth CS, Jones A, Selby PL, Adams JE, Mawer EB, Webb AK. Randomised, double blind, placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adults with cystic fibrosis [abstract]. Pediatric Pulmonology 2001;32(Suppl 22):330-1.
18. * Haworth CS, Jones AM, Adams JE, Selby PL, Webb AK. Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis. Journal of Cystic Fibrosis 2004;3(4):233-6.
19. Kane 1991 {published data only} Kane RE, Hobbs P. Energy and respiratory metabolism in cystic fibrosis: the influence of carbohydrate content of nutritional supplements. Journal of Pediatric Gastroenterology and Nutrition 1991;12:217-23.
20. Lepage 2002 {published data only} Lepage G, Yesair DW, Ronco N, Champagne J, Bureau N, Chemtob S, et al.Effect of an organized lipid matrix on lipid absorption and clinical outcomes in patients with cystic fibrosis. Journal of Pediatrics 2002;141(2):178-85.
21. Lloyd-Still 2001 {published data only} Lloyd-Still J, Powers CA, Hoffman DR, Boyd-Trull K, Lester LA, Benisek DC, et al.A randomized, controlled study examining the bioavailability and safety of an algal docosahexaenoic acid (DHA) triacylglycerol in cystic fibrosis (CF) patients [abstract]. Pediatric Pulmonology 2004;38(Suppl 27):331.
22. Lloyd-Still JD, Powers CA, Hoffman DR, Arterburn LM, Benisek DC, Lester LA. Bioavailability and safety of an algal docosahexaenoic acid (DHA) triglyceride in cystic fibrosis (CF) [abstract]. Pediatric Research 2001;49(4 Suppl):455a.
23. Lloyd-Still JD, Powers CA, Hoffman DR, Boyd-Trull K, Arterburn LM, Benisek DC, et al.Blood and tissue essential fatty acids after docosahexaenoic acid supplementation in cystic fibrosis [abstract]. Pediatric Pulmonology 2001;Suppl 22:263.
24. * Lloyd-Still JD, Powers CA, Hoffman DR, Boyd-Trull K, Lester LA, Benisek DC, et al.Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study. Nutrition 2006;22(1):36-46.
25. Powers CA, Lloyd-Still JD, Hoffman DR, Arterburn LM, Benisek DC, Lester LA. Lipid soluble antioxidant status during supplementation with algal docosahexaenoic acid triglyceride in CF [abstract]. Proceedings of 24th European Cystic Fibrosis Conference; 2001 June 6-9; Vienna, Austria. 2001:P133.
26. McKenna 1985 {published data only} McKenna MC, Hubbard VS, Bieri JG. Linoleic acid absorption from lipid supplements in patients with cystic fibrosis with pancreatic insufficiency and in control subjects. Journal of Pediatric Gastroenterology and Nutrition 1985;4(1):45- 51.
27. Milla 1996 {published data only} Milla C, Doherty L, Raatz S, Schwarzenberg SJ, Regelmann W, Moran A. Glycemic response to dietary supplements in cystic fibrosis is dependent on the carbohydrate content of the formula. Journal of Parenteral and Enteral Nutrition 1996;20:182- 6.
28. Oudshoorn 2007 {published data only} Oudshoorn JH, Klijn PH, Hofman Z, Voorbij HA, van der Ent CK, Berger R, et al.Dietary supplementation with multiple micronutrients: no beneficial effects in pediatric cystic fibrosis patients. Journal of Cystic Fibrosis 2007;6(1):35-40.
29. Papas 2007 {published data only} Papas K, Kalbfleisch J, Mohon R. Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients. Digestive Diseases and Sciences 2007;52(2):347-52.
30. Patchell 2001 {published data only (unpublished sought but not used)} Barrett J. A study to assess the efficacy of Healthshake in the nutritional management of children and adults with cystic fibrosis. Start date: 1/7/98; End date: 30/6/99. National Research Register (UK) http://www.update- software.com/national/ 2001. Patchell C. Personal Communication March 05 2001.
31. Sondel 1987 {published data only} Sondel SA, Parrell SW, Becker D, Mischler EH. Oral nutritional supplementation in cystic fibrosis. Nutritional Support Services 1987;7(4):20-2.
32. Steinkamp 2000 {published data only} Koletzko B, Ruhl-Bagheri I, Thiel I, Steinkamp G. Effects of a formula supplement rich in linoleic acid on the essential fatty acid status of cystic fibrosis patients [abstract]. Clinical Nutrition 1992;11(Suppl):39-40.
33. Steinkamp G, Demmelmair H, Ruhl-Bagheri I, von der Hardt H, Koletzko B. Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients. Journal of Pediatric Gastroenterology and Nutrition 2000;31:418-23.
34. MacDonald 2001 {published data only} MacDonald A. Evaluation of supplementary feed (Healthshake) in the nutritional management of children with cystic fibrosis. Start date: 1/1/97; End date: 1/1/98. National Research Register (UK) http://www.update-software.com/national/ 2001.
35. MacDonald 1996 MacDonald A. Nutritional management of cystic fibrosis. Archives of Disease in Childhood 1996;74(1):81-7.
36. Marin 2004 Marin VB, Velandia S, Hunter B, Gattas V, Fielbaum O, Herrara O, et al.Energy expenditure, nutrition status and body composition in children with cystic fibrosis. Nutrition 2004;20(2):181-6.
37. Murray 1991 Murray GD. Statistical aspects of research methodology. British Journal of Surgery 1991;78(7):777-81.
38. Poustie 1999 Poustie V, Rutherford P. Oral protein calorie supplementation for children with chronic disease. Cochrane Database of Systematic Reviews 1999, Issue 3. [DOI: 10.1002/14651858]
39. RLCH 2006 Royal Liverpool Children's Hospital NHS Trust [Pharmacy]. Personal communication 2006.
40. Shepherd 1980 Shepherd R, Cooksley WGE, Cooke WDD. Improved growth and clinical, nutritional and respiratory changes in response to nutritional therapy in cystic fibrosis. Journal of Pediatrics 1980;97(3):351- 7.
41. Shepherd 1988 Shepherd RW, Holt TL, Vasques-Velasquez L, Coward WA, Prentice A, Lucas A. Increased energy expenditure in young children with cystic fibrosis. Lancet 1988;I(8598):1300-3.
42. Sinaasappel 2002 Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HG. Nutrition in patients with cystic fibrosis; a European consensus. Journal of Cystic Fibrosis 2002;1(4):51-75.
43. Smyth 2000 Smyth RL, Walters S. Oral calorie supplements for cystic fibrosis. Cochrane Database of Systematic Reviews 2000, Issue 1. [DOI: 10.1002/14651858]